<i>Kif15</i> deficiency affects the expression of Gephyrin and GABRB1 in PFC and hippocampus. by Xiaomei He (795333)

<i>Kif15</i> deletion results in abnormal distribution of PSD95 in neuropil. by Xiaomei He (795333)

Cochrane Collaboration’s risk of bias tool. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”

Supplementary data. by Malte Ostendarp (13217973)

<i>Kif15</i> deficiency leads to impaired development of dendritic spines in PFC and hippocampus of mice. by Xiaomei He (795333)

Grade system. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”

Literature search. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”

Study characteristics. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”

Flowchart of literature retrieval. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”

Data extraction. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Comparison of sleep and activity the night before and after surgery in Experiment 1. by Akihiro Ohnishi (10989900)

Comparison of postoperative rest and activity between APS score groups in Experiment 2. by Akihiro Ohnishi (10989900)

Data from qPCR analysis of hemolymph from included clams. by Rachael M. Giersch (22331947)

Data from qPCR analysis of eDNA and matching hemolymph timepoints. by Rachael M. Giersch (22331947)

Chromatograms presented the specificity of the proposed method. by Ewa Paszkowska (21246702)

Characteristics and outcomes from clams with MarBTN and control healthy clams. by Rachael M. Giersch (22331947)

Changepoint analysis in comparison of MarBTN-specific eDNA and cancer in hemolymph. by Rachael M. Giersch (22331947)

Survival of soft-shell clams with MarBTN compared to control clams. by Rachael M. Giersch (22331947)

Phylogenetic tree of <i>Anaplasma ovis</i> based on the partial <i>msp4</i> gene sequences available in GenBank. by Sumaira Sumaira (21453523)